The Next Frontier in Digital Therapeutics

HOMEOSTAT is a breakthrough research initiative that introduces a novel class of wearable therapeutics designed to stimulate the body’s intrinsic healing systems. Through real-time, non-invasive mechanical stimulation delivered via intelligent motorised bands, HOMEOSTAT activates cytokine modulation, vascular protection, and autonomic rebalancing—unlocking a high-impact, drug-free approach to improving systemic resilience.
This wearable platform integrates non-pneumatic, motorised occlusion bands, PPG (photoplethysmography) sensors, and an adaptive mobile app that precisely controls stimulation cycles based on the user’s own physiology. The result is a safe, scalable, and comfortable device that transitions smoothly from clinical research to practical health interventions.
While HOMEOSTAT is currently under evaluation for EU Pathfinder funding, it reflects a fully conceptualised and tested innovation framework—and we are excited to share our vision with stakeholders, partners, and the world.

TRACTION: Patents & Research Papers

Qloud Technologies already holds two patents related to RIPC devices and logic, providing a solid foundation for future IP development and commercial scaling.
How It Works
Intelligent Stimulation. Biological Activation.
HOMEOSTAT delivers controlled, short-duration compression to the limbs. These cycles mimic physiological stress signals, such as ischemia-reperfusion, which trigger the body’s homeostatic defense mechanisms.


Unlike oscillometric or pneumatic cuff devices, HOMEOSTAT features no pumps, no sizing issues, and no clinical setup—just wearable, app-based autonomy.

The Technology

From Stimulus to Adaptation: An Integrated System

HOMEOSTAT merges next-generation wearable design with digital physiology
  • Motorized, non-pneumatic bands – quiet and precise
  • PPG sensors – track perfusion and vascular tone
  • Bluetooth microcontroller – connects hardware and app
  • Smartphone app – user or algorithm-driven control
  • Adaptive algorithms – real-time physiological response
  • Battery-powered, lightweight – use anywhere
HOMEOSTAT’s protocol engine supports three modes
  • Remote Ischemic Preconditioning (RIPC)
  • Blood Flow Restriction (BFR)
  • Cardiovascular Monitoring

Planned Demonstrators

Clinical Proof of Concept in Real-World Scenarios

The HOMEOSTAT project will validate its system through three clinical demonstrators hosted at leading institutions:

  • 1) MGH (USA): Maps cytokine response; focuses on safety, comfort, biomarkers, and endothelial function.
  • 2) AUTH (Greece): Tests BFR for rehab; evaluates strength, lactate, safety, and usability.
  • 3) UPO (Italy): Explores cardioprotection pre-CT-PCI; targets biomarkers, integration, and comfort.
Each study targets a unique therapeutic angle—prehabilitation, recovery, or procedural resilience—anchored by real-world performance indicators and user feedback.

Next Planned Research

HOMEOSTAT in Cancer Care: A Universal Homeostasis Approach

  • Support Across Cancer Stages: Maintains physiological balance from diagnosis to recovery.
  • Real-Time Monitoring: Detects early health decline via continuous vitals tracking.
  • Prehabilitation: Boosts readiness with personalized training and stress relief.
  • Treatment Safety: Prevents heart, kidney, and liver toxicity during therapy.
  • Recovery Assistance: Guides rehab through recovery tracking.
  • Smart Interface: Connects body and therapy to maintain balance.
  • New Oncology Approach: Focuses on homeostasis for better outcomes.
Benefits
01

Drug-free modulation of inflammation and vascular repair
02

Enhances physiological recovery post-exercise, post-surgery, or post-procedure
03

Safe, precise, and easy to use, with no sizing limitationse
04

PPG-guided control allows real-time personalisation
05

Usable in hospitals, gyms, or at home
06

Scalable to cardio, cancer, and performance care.

Homeostat Goes Global

Although still in development, HOMEOSTAT is already attracting attention for its potential to transform

We are actively pursuing clinical validation, regulatory preparation, and partnership opportunities to make HOMEOSTAT a standard in digital health.

Get Involved

Whether you’re a clinician, researcher, investor, or technologist—join us in shaping the future of programmable therapeutics.

Contact Us Access Concept Note Partner With Us